Related Experiment Video

Updated: Aug 9, 2026

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines
09:46

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Curative properties of muramyl dipeptide in experimental Naegleria meningoencephalitis

A Ferrante, E Lederer

    Transactions of the Royal Society of Tropical Medicine and Hygiene
    |January 1, 1986
    PubMed

    Insights

    Immunostimulants like MDP offer potential treatments for Naegleria fowleri infections. Studies show these agents can protect mice and cure existing infections, suggesting a new therapeutic avenue.

    Area of Science:

    • Neuroparasitology
    • Immunology
    • Infectious Diseases

    Background:

    • Naegleria fowleri is a deadly amoeba causing primary amoebic meningoencephalitis (PAM).
    • Current treatments for PAM are limited and often ineffective.

    Purpose of the Study:

    • To investigate the potential of immunostimulants as a therapeutic strategy against Naegleria fowleri infections.
    • To evaluate the efficacy of MDP and attenuated Salmonella enteritidis in preventing and treating PAM in a mouse model.

    Main Methods:

    • Mice were treated with Muramyl dipeptide (MDP) or an attenuated strain of Salmonella enteritidis.
    • Mice were intranasally challenged with Naegleria fowleri.
    • Therapeutic efficacy was assessed in mice exhibiting symptoms of naegleria meningoencephalitis.

    Main Results:

    • Mice treated with MDP or Salmonella enteritidis demonstrated resistance to N. fowleri challenge.
    • A single injection of MDP cured mice already infected with N. fowleri and showing disease symptoms.

    Conclusions:

    • Immunostimulants, particularly MDP, show promise as a novel therapeutic approach for Naegleria fowleri infections.
    • Further research into immunostimulant-based therapies could lead to effective treatments for PAM.

    More Related Videos

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection05:55

    Induction of Leptomeningeal Cells Modification Via Intracisternal Injection

    Published on: May 7, 2020

    The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials08:36

    The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

    Published on: April 19, 2024

    Related Concept Videos

    Bacterial Meningitis01:24

    Bacterial Meningitis

    Bacterial meningitis is a severe infectious disease involving inflammation of the meninges, the protective membranes surrounding the brain and spinal cord. It occurs when pathogenic bacteria cross the blood–brain barrier and enter the cerebrospinal fluid. Common causative organisms include Neisseria meningitidis, Streptococcus pneumoniae, Haemophilus influenzae type b, Listeria monocytogenes, and Escherichia coli K1. The exact route of entry varies by pathogen and host condition.Routes of Entry...
    Viral Meningitis01:18

    Viral Meningitis

    Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
    Cryptococcal Meningitis01:27

    Cryptococcal Meningitis

    Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
    Bacterial Meningitis II: Pathophysiology01:26

    Bacterial Meningitis II: Pathophysiology

    Bacterial meningitis typically begins when pathogens such as Neisseria meningitidis and Streptococcus pneumoniae colonize the nasopharynx and invade the bloodstream. This process is facilitated by bacterial virulence factors, such as polysaccharide capsules, which resist phagocytosis and complement-mediated killing. Less commonly, bacteria reach the central nervous system via contiguous spread from infections like otitis media or sinusitis, through congenital or acquired dural defects, or...
    Encephalitis ll: Pathophysiology01:26

    Encephalitis ll: Pathophysiology

    Encephalitis is inflammation of the brain parenchyma caused by direct viral invasion or immune-mediated mechanisms triggered by infections or tumors. Both processes lead to neuronal injury, disrupted neurotransmission, and diverse neurological symptoms, often with overlapping clinical and pathological features.Autoimmune EncephalitisIn autoimmune encephalitis, antibodies target neuronal antigens on cell surfaces, synapses, or within neurons. A key example is anti-NMDAR encephalitis, which can...